Mehdi Razavi

Mehdi Razavi has an extensive work experience in the field of cardiology and biomedical research. Mehdi has been the Director of Clinical Arrhythmia Research and Innovations at the Texas Heart Institute since 2013. In 2018, they co-founded Maxwell Biomedical Inc. and serves as a Co-Founder. Mehdi is also an Adjunct Associate Professor of Biongineering at Rice University starting from 2017. Mehdi Razavi has been an Associate Professor of Medicine (Cardiology/Electrophysiology) at Baylor College of Medicine since 2015, where they specialize in complex cardiac ablations and cardiac rhythm device implantations. Along with their work in academia and research, they have co-founded nanolinea in 2013 and is a board member of Saranas since 2014. Prior to their current positions, they worked as a Physician at Texas Health Institute from 2012. Overall, Mehdi Razavi has a diverse background in clinical, academic, and entrepreneurial roles in the field of cardiology.

Mehdi Razavi pursued their education in a chronological manner. Starting in 1991, they attended the University of Maryland Baltimore County, where they obtained a Bachelor of Science degree in Biology, with a focus on General Biology. Mehdi continued their academic journey from 1995 to 2002 at the Mayo Clinic Graduate School of Biomedical Sciences, where they achieved a Medical Doctor (M.D.) degree specializing in Cardiology and Electrophysiology.